Research

What research is being done on CP?

Presently, there are almost 1 million American adults and children with cerebral palsy (CP) — and still another 50+ million with other disabilities. While prevention research remains a priority, funding for clinical trials is needed in order to provide evidence-based clinical care that can improve functionality, as well quality of life for those with developmental disabilities. There have been many advances in treating other neurological conditions such as adult stroke and spinal injury that may have a role in restoring motor and cognitive function in persons with CP. Despite advances in the prevention of CP, the incidence has increased 25% over the last decade and is likely attributable to the concomitant increases in the number of multiple fetal births and improved neo-natal care. Decisions to select any course of treatment should always be made after consultation with his or her professional provider.

The UCP Research and Educational Foundation

The UCP Research and Educational Foundation is the nation’s principal non-government agency sponsoring research directly relevant to the prevention of cerebral palsy and improvement in the quality of life of persons with disabilities due to cerebral palsy and related developmental brain disorders. In its history of more than 50 years, the Foundation has been instrumental in eliminating two of the major causes of cerebral palsy, German measles and maternal-child blood type incompatibility. The Foundation is now focusing its attention on other remaining major causes such as low birth weight, prematurity, and the effects of maternal infection on the developing brain. It is also exploring the development of improved methods for mobility, communication and the general well being of children and adults with developmental disorders of the brain as well as the possibility of replacing lost cells in the brain. The Foundation also serves as the medical and scientific information resource for UCP, its affiliates, the clinical professions and the public.